Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Inv. Zdp 29 Regulatory News (EJFZ)

Share Price Information for Ejf Inv. Zdp 29 (EJFZ)

Share Price is delayed by 15 minutes
Get Live Data
109.50    0.00 (0.00%)
Bid:
108.00
Ask:
111.00
Spread: 3.00 (2.778%)
Market Cap: -
EJFZ Live PriceLast checked at - London Stock Exchange

Intraday Ejf Inv. Zdp 29 Share Chart

Tender Offer

1 Sep 2025 07:00

RNS Number : 2794X
EJF Investments Ltd
01 September 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

 

 

01 September 2025

 

 

EJF Investments Limited (the "Company" or "EJFI")

 

EJFI Announces Tender Offer of 5% of its Ordinary Shares

The Board of EJFI, which provides investors exposure to primarily a diversified portfolio of debt issued by smaller U.S. banks and insurance companies, and participation in certain management fee income streams of EJF Capital LLC, is pleased to announce its intention to conduct the Company's first tender offer for up to 5% of Ordinary Shares in issue at a 5% discount to the Company's NAV per share (adjusted for the costs of the tender offer). The Company expects to publish a formal tender document to Ordinary Shareholders during the middle of September, which will contain full details of the tender offer, including the tender price, which is expected to be calculated by reference to the NAV per share at 31 August 2025.

On 27 November 2024, the Company announced the introduction of a periodic tender offer mechanism (referred to as the "Liquidity Option") whereby Ordinary Shareholders would be offered the opportunity (at the Board's discretion) to tender some or all of their respective holdings of ordinary shares, subject to this not exceeding an aggregate maximum of 5% of the Ordinary Shares in issue in a 12-month period. The Liquidity Option was approved by shareholders on 17 December 2024.

The Liquidity Option was introduced in recognition of the ongoing discount to NAV at which the Company's Ordinary Shares have traded. Whilst the Company's long-term objective is to increase its scale, it would like to provide an opportunity for Ordinary Shareholders to receive a return of capital for their Ordinary Shares at a premium to the Company's current prevailing share price whilst also providing an element of NAV per Ordinary Share accretion to all Ordinary Shareholders. Although the Company has seen a reduction over the year in the discount at which its Ordinary Shares trade, reducing from 27.3% at the start of the financial year to the current level of 25.0%, the Board considers it in the best interests of shareholders to implement the Liquidity Option and provide Ordinary Shareholders with the opportunity to realise a proportion of their investment at a significantly tighter discount.

John Kingston III, the Company's Chair, stated: "Although the Manager has taken constructive steps to narrow the discount meaningfully over the past 12 months and the share price has increased 27.5% over that period, the Board is determined to have the Company's shares trade closer to net asset value. The Board therefore believes that a 5% tender at a 5% discount, consistent with the authority granted by the shareholders, is the next best step to continue reducing the Company's trading discount." Mr. Kingston also noted that the Company has provided a Total Return (inclusive of dividends) of 97.79% from its inception in 2017 to 31 July 2025.

None of the Ordinary Shares held by the members of the Board will be tendered under this offer. The Manager has also informed the Board that none of the principals of the Manager or EJF Capital Limited (an affiliate of the Manager) intend to tender Ordinary Shares under this offer. The Manager and its affiliates currently hold approximately 26% of the Company's Ordinary Shares.

 

ENQUIRIES

For the Investment Manager

EJF Investments Manager LLC

Mungo Hargreaves / Jay Ghatalia

MHargreaves@ejfcap.com / jghatalia@ejfcap.com

+44 20 3752 6775 / +44 203 752 6776

 

For the Company Secretary and Administrator

Apex Financial Services (Alternative Funds) Limited 

ejficosec@apexgroup.com 

+44 204 549 0721 

 

For the Broker

Panmure Liberum Limited

Darren Vickers / Ashwin Kohli

 +44 203 100 2222

 

Barclays Bank PLC

Dion Di Miceli/Stuart Muress/James Atkinson 

BarclaysInvestmentCompanies@barclays.com

+44 207 623 2323

 

About EJF Investments Limited

EJFI's objective is to provide shareholders with attractive risk adjusted returns through regular dividends and capital growth over the long term. EJFI generates exposure primarily to a diversified portfolio of loans issued by financial institutions and related or similar assets in the U.S., U.K. and Europe.

 

EJFI currently invests primarily in CDO Equity Tranches structured by an affiliate of EJF Capital LLC, providing levered exposure to a highly diversified portfolio of securities issued by U.S. financial institutions (banks and insurance companies), these being Risk Retention Investments.

 

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

 

LEI: 549300XZYEQCLA1ZAT25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENUKOORVWUWUAR
Date   Source Headline
9th Mar 20209:41 amRNSBuy-back Programme
5th Mar 20209:25 amRNSCorporate Update
26th Feb 20204:56 pmRNSPDMR Dealing
26th Feb 20201:35 pmRNSHolding(s) in Company
24th Feb 202010:17 amRNSHolding(s) in Company
20th Feb 20207:00 amRNSNet Asset Value(s)
20th Feb 20207:00 amRNSNet Asset Value(s)
28th Jan 20204:36 pmRNSDirector/PDMR Shareholding
23rd Jan 20205:45 pmRNSDividend Declaration
22nd Jan 20207:00 amRNSNet Asset Value(s)
16th Jan 20203:56 pmRNSRecent Investment Announcement
3rd Jan 202011:58 amRNSAppointment of The ID Register
30th Dec 20194:33 pmRNSPDMR Dealings
20th Dec 20197:00 amRNSNet Asset Value(s)
19th Dec 20193:06 pmRNSPublication of Supplementary Prospectus
19th Dec 20197:00 amRNSRecent Investment Announcement
18th Dec 20196:30 pmRNSResult of Extraordinary General Meeting
22nd Nov 20194:47 pmRNSNotice of Extraordinary General Meeting
21st Nov 20197:00 amRNSNet Asset Value(s)
13th Nov 20194:06 pmRNSRecent Investment Announcement
12th Nov 201911:50 amRNSCorporate Update
23rd Oct 20195:08 pmRNSDividend Declaration
21st Oct 20197:00 amRNSNet Asset Value(s)
23rd Sep 20199:48 amRNSRecent Investment Announcement
20th Sep 20197:00 amRNSNet Asset Value(s)
13th Sep 20193:35 pmRNSDirector/PDMR Shareholding
9th Sep 201910:27 amRNSHolding(s) in Company
6th Sep 201911:46 amRNSHolding(s) in Company
3rd Sep 20193:10 pmRNSDirector/PDMR Shareholding
30th Aug 20194:08 pmRNSRecent Investment Announcement
23rd Aug 20194:22 pmRNSHalf-year Report
20th Aug 20197:00 amRNSNet Asset Value(s)
26th Jul 20194:25 pmRNSDividend Declaration
19th Jul 20197:00 amRNSNet Asset Value(s)
9th Jul 20194:10 pmRNSPDMR Dealings
3rd Jul 20199:27 amRNSHolding(s) in Company
26th Jun 20194:12 pmRNSHolding(s) in Company
24th Jun 20194:00 pmRNSPublication of Prospectus and Placing Programme
21st Jun 20193:54 pmRNSResult of AGM
21st Jun 20197:00 amRNSNet Asset Value(s)
13th Jun 20194:11 pmRNSDirector Declaration
13th Jun 20199:34 amRNSCorporate Update
29th May 201910:34 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSNet Asset Value(s)
17th May 20194:00 pmRNSNotice of AGM
1st May 20197:00 amRNSChange of Company Secretary and Registered Office
1st May 20197:00 amRNSCorporate Update
26th Apr 20193:55 pmRNSDividend Declaration
17th Apr 20194:13 pmRNSInvestment Update
17th Apr 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.